UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income	$ (22,672)	$ (5,883)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	26,251	24,147
Stock-based compensation expense	5,510	8,286
Deferred income taxes	17,223	5,484
Provision for doubtful accounts	1,503	152
Amortization of fees on debt	410	404
Noncash operating lease expense	3,866	5,005
Other	(3,918)	4,325
Changes in assets and liabilities:
Accounts receivable	(126,521)	(150,263)
Inventories, prepaid expenses, deposits and other current and long-term assets	(34,695)	1,260
Accounts payable	8,425	(1,256)
Accrued liabilities	(9,971)	(2,464)
Accrued compensation and benefits	(32,805)	(44,395)
Operating lease liability	(2,605)	(5,321)
Deferred revenue and other liabilities	26,853	29,009
Net cash used in operating activities	(143,146)	(131,510)
Cash flows from investing activities
Purchase of property and equipment	(913)	(1,278)
Capitalized software development costs	(9,793)	(9,690)
Capitalized curriculum development costs	(6,145)	(4,376)
Sale of other investments	60
Acquisition of assets	(1,409)
Other acquisitions, loans and investments, net of distributions	(213)	(192)
Proceeds from the maturity of marketable securities	12,044	1,501
Purchases of marketable securities	(20,126)	(9,196)
Net cash used in investing activities	(26,495)	(23,231)
Cash flows from financing activities
Repayments on finance lease obligations	(9,314)	(7,020)
Payments of contingent consideration	(7,024)
Proceeds from exercise of stock options	10	246
Repurchase of restricted stock for income tax withholding	(8,905)	(6,043)
Net cash used in financing activities	(25,233)	(12,817)
Net change in cash, cash equivalents and restricted cash	(194,874)	(167,558)
Cash, cash equivalents and restricted cash, beginning of period	389,398	386,582
Cash, cash equivalents and restricted cash, end of period	$ 194,524	$ 219,024